Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Grunseich

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2020
RNA abasic sites in yeast and human cellsYaojuan Liu, Yesenia Rodriguez, Robert L Ross, et al.
Neurology|November 17, 2017
Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophyRobert D Guber, Varun Takyar, Angela Kokkinis, et al.
Annals of Clinical and Translational Neurology|August 15, 2015
A randomized controlled trial of exercise in spinal and bulbar muscular atrophyJoseph A Shrader, Ilona Kats, Angela Kokkinis, et al.
Neuromuscular Disorders : NMD|July 23, 2014
Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeatChristopher Grunseich, Ilona R Kats, Laura C Bott, et al.
Skeletal Muscle|August 22, 2025
NAD<sup>+</sup> dyshomeostasis in RYR1-related myopathiesTokunbor A Lawal, Willa Riekhof, Linda Groom, et al.
Neuron|January 9, 2015
Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophyChiara Scaramuzzino, Ian Casci, Sara Parodi, et al.
Acta Neuropathologica|May 5, 2018
Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patientsCraig L Bennett, Somasish G Dastidar, Shuo-Chien Ling, et al.
The Lancet. Neurology|October 20, 2018
Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trialChristopher Grunseich, Ram Miller, Therese Swan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 9, 2021
Improving the efficacy of exome sequencing at a quaternary care referral centre: novel mutations, clinical presentations and diagnostic challenges in rare neurogenetic diseasesChristopher Grunseich, Nathan Sarkar, Joyce Lu, et al.
Molecular Cell|February 4, 2018
Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene PromotersChristopher Grunseich, Isabel X Wang, Jason A Watts, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2020
RNA abasic sites in yeast and human cellsYaojuan Liu, Yesenia Rodriguez, Robert L Ross, et al.
Neurology|November 17, 2017
Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophyRobert D Guber, Varun Takyar, Angela Kokkinis, et al.
Annals of Clinical and Translational Neurology|August 15, 2015
A randomized controlled trial of exercise in spinal and bulbar muscular atrophyJoseph A Shrader, Ilona Kats, Angela Kokkinis, et al.
Neuromuscular Disorders : NMD|July 23, 2014
Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeatChristopher Grunseich, Ilona R Kats, Laura C Bott, et al.
Skeletal Muscle|August 22, 2025
NAD<sup>+</sup> dyshomeostasis in RYR1-related myopathiesTokunbor A Lawal, Willa Riekhof, Linda Groom, et al.
Neuron|January 9, 2015
Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophyChiara Scaramuzzino, Ian Casci, Sara Parodi, et al.
Acta Neuropathologica|May 5, 2018
Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patientsCraig L Bennett, Somasish G Dastidar, Shuo-Chien Ling, et al.
The Lancet. Neurology|October 20, 2018
Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trialChristopher Grunseich, Ram Miller, Therese Swan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 9, 2021
Improving the efficacy of exome sequencing at a quaternary care referral centre: novel mutations, clinical presentations and diagnostic challenges in rare neurogenetic diseasesChristopher Grunseich, Nathan Sarkar, Joyce Lu, et al.
Molecular Cell|February 4, 2018
Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene PromotersChristopher Grunseich, Isabel X Wang, Jason A Watts, et al.
Pageof 8